Advertisement

Correction to: A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL

  • Jung Jin Hwang
  • Yong Sook Kim
  • Taelim Kim
  • Mi Joung Kim
  • In Gab Jeong
  • Je-Hwan Lee
  • Jene Choi
  • Sejin Jang
  • Seonggu Ro
  • Choung-Soo KimEmail author
Correction
  • 113 Downloads

Correction to: Invest New Drugs (2012) 30:1434–1442

  https://doi.org/10.1007/s10637-011-9718-1

The blots of control and docetaxel for caspase-9, caspase-3, caspase-8, Bcl-XL, and tubulin in the Figure 4f were reused from Figure 4 of our previous paper published in Journal of Urology in 2010 ( https://doi.org/10.1016/j.juro.2010.07.035).

Notes

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Jung Jin Hwang
    • 1
    • 2
  • Yong Sook Kim
    • 2
  • Taelim Kim
    • 2
  • Mi Joung Kim
    • 2
  • In Gab Jeong
    • 3
  • Je-Hwan Lee
    • 4
  • Jene Choi
    • 5
  • Sejin Jang
    • 5
  • Seonggu Ro
    • 6
  • Choung-Soo Kim
    • 3
    Email author
  1. 1.Department of Convergence MedicineUniversity of Ulsan College of Medicine, Asan Medical CenterSeoulSouth Korea
  2. 2.Institute for Innovative Cancer ResearchUniversity of Ulsan College of Medicine, Asan Medical CenterSeoulSouth Korea
  3. 3.Department of UrologyUniversity of Ulsan College of Medicine, Asan Medical CenterSeoulSouth Korea
  4. 4.Department of Internal Medicine & Laboratory MedicineUniversity of Ulsan College of Medicine, Asan Medical CenterSeoulSouth Korea
  5. 5.Department of PathologyUniversity of Ulsan College of Medicine, Asan Medical CenterSeoulSouth Korea
  6. 6.PiMedBio, Inc.SeoulSouth Korea

Personalised recommendations